CN102441129A - Traditional Chinese medicine for treating chronic pulmonary heart disease - Google Patents
Traditional Chinese medicine for treating chronic pulmonary heart disease Download PDFInfo
- Publication number
- CN102441129A CN102441129A CN2011103976125A CN201110397612A CN102441129A CN 102441129 A CN102441129 A CN 102441129A CN 2011103976125 A CN2011103976125 A CN 2011103976125A CN 201110397612 A CN201110397612 A CN 201110397612A CN 102441129 A CN102441129 A CN 102441129A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- semen
- heart disease
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
The invention relates to a traditional Chinese medicine for treating the chronic pulmonary heart disease. The traditional Chinese medicine comprises the following raw materials, by weight, 10-15 parts of ginseng, 10-15 parts of Radix Ophiopogonis, 10-15 parts of Chinese magnoliavine, 10-15 parts of Rhizoma Atractylodis Macrocephalae, 10-15 parts of Sappanwood, 5-8 parts of Cassia Twig, 10-15 parts of Radix Astragali, 10-15 parts of Salvia miltiorrhiza, 10-15 parts of salted aconite root, 8-12 parts of Tokay Gecko, 10-15 parts of epimeddium, 10-15 parts of Chinese yam, 10-15 parts of bitter apricot kernel, 10-15 parts of Malaytea Scurfpea Fruit, 10-15 parts of Pepperweed Seed, 10-15 parts of Stemona sessilifolia, 10-15 parts of Poria cocos, 10-15 parts of peach kernel, 10-15 parts of Common Coltsfoot Flower, 5-8 parts of fried licorice, 10-15 parts of lumbricus and 10-15 parts of Herba Houttuyniae. The traditional Chinese medicine for treating the chronic pulmonary heart disease of the invention has the advantages of simple preparation method, easily controlled quality, high cure rate, difficult recurrence, and no toxic side effect.
Description
Technical field
The present invention relates to a kind of Chinese medicine that is used to treat chronic pulmonary heart disease.
Background technology
Chronic pulmonary heart disease; Be called for short chronic cardiopulmonary disease, be chronic pathological changes by lung tissue, lung blood vessel or thorax cause lung tissue structure and (or) dysfunction, producing pulmonary vascular resistance increases; Pulmonary artery pressure increases; Make right ventricle or (with) plumpness, companion or do not accompany the depleted heart disease of right heart function, and get rid of congenital heart disease and left cardiopathia becomes causer.Clinical manifestation is cough, expectoration, tachypnea, and movable back cardiopalmus, dyspnea, weak and work tolerance descend, and dyspnea increases the weight of during serious attack, limitation of activity, and appetite descends, even respiratory failure, right heart failure occur and threat to life.At present, the treatment pulmonary heart disease does not have specific drug, most with antiinflammatory, cough-relieving, relieving asthma or treat with the cardiopathic medicine of treatment, but effect is very undesirable, recurrence and mortality rate height very easily.
Summary of the invention
The present invention is directed to the above-mentioned deficiency that chronic pulmonary heart disease exists in treatment, a kind of Chinese medicine that is used to treat chronic pulmonary heart disease is provided.
The technical scheme that the present invention solves the problems of the technologies described above is following: a kind of raw material and parts by weight thereof that are used to treat the Chinese medicine of chronic pulmonary heart disease comprise: 10～15 parts of Radix Ginsengs; 10～15 parts of Radix Ophiopogonis; 10～15 parts of Fructus Schisandrae Chinensis; 10～15 parts of the Rhizoma Atractylodis Macrocephalaes; 10～15 parts of Lignum Sappans; 5～8 parts of Ramulus Cinnamomi; 10～15 parts of the Radixs Astragali; 10～15 parts of Radix Salviae Miltiorrhizaes; 10～15 parts of Radix Aconiti Lateralis Preparata; 8～12 parts of Geckos; 10～15 parts of Herba Epimedii; 10～15 parts of Rhizoma Dioscoreaes; 10～15 parts of Semen Armeniacae Amarums; 10～15 parts of Fructus Psoraleaes; 10～15 parts of Semen Lepidii (Semen Descurainiae)s; 10～15 parts of the Radixs Stemonae; 10～15 parts in Poria; 10～15 parts in Semen Persicae; 10～15 parts of Flos Farfaraees; 5～8 parts of Radix Glycyrrhizae Preparatas; 10～15 parts of 10～15 parts of Pheretimas and Herba Houttuyniae.
On the basis of technique scheme, the present invention can also do following improvement.
Further, the raw material of said Chinese medicine and parts by weight thereof comprise: 11～14 parts of 11～14 parts of Radix Ginsengs, 11～14 parts of Radix Ophiopogonis, 11～14 parts of Fructus Schisandrae Chinensis, 11～14 parts of the Rhizoma Atractylodis Macrocephalaes, 11～14 parts of Lignum Sappans, 5～7 parts of Ramulus Cinnamomi, 11～14 parts of the Radixs Astragali, 11～14 parts of Radix Salviae Miltiorrhizaes, 11～14 parts of Radix Aconiti Lateralis Preparata, 9～11 parts of Geckos, 11～14 parts of Herba Epimedii, 11～14 parts of Rhizoma Dioscoreaes, 11～14 parts of Semen Armeniacae Amarums, 11～14 parts of Fructus Psoraleaes, 11～14 parts of Semen Lepidii (Semen Descurainiae)s, 11～14 parts of the Radixs Stemonae, 11～14 parts in Poria, 11～14 parts in Semen Persicae, 11～14 parts of Flos Farfaraees, 5～7 parts of Radix Glycyrrhizae Preparatas, 11～14 parts of Pheretimas and Herba Houttuyniae.
Further, the raw material of said Chinese medicine and parts by weight thereof comprise: 12 parts of 12 parts of Radix Ginsengs, 12 parts of Radix Ophiopogonis, 12 parts of Fructus Schisandrae Chinensis, 12 parts of the Rhizoma Atractylodis Macrocephalaes, 12 parts of Lignum Sappans, 6 parts of Ramulus Cinnamomi, 12 parts of the Radixs Astragali, 12 parts of Radix Salviae Miltiorrhizaes, 12 parts of Radix Aconiti Lateralis Preparata, 10 parts of Geckos, 12 parts of Herba Epimedii, 12 parts of Rhizoma Dioscoreaes, 12 parts of Semen Armeniacae Amarums, 12 parts of Fructus Psoraleaes, 12 parts of Semen Lepidii (Semen Descurainiae)s, 12 parts of the Radixs Stemonae, 12 parts in Poria, 12 parts in Semen Persicae, 12 parts of Flos Farfaraees, 6 parts of Radix Glycyrrhizae Preparatas, 12 parts of Pheretimas and Herba Houttuyniae.
The invention has the beneficial effects as follows: the present invention is used to treat the Chinese medicine of chronic pulmonary heart disease, is under instruction of Chinese Medicine theory, and concentrating on studies forms, and adopts " strengthening the body resistance, vital energy regualting and blood circulation-promoting " method.Focus on and transfer reinforcing the heart, lung, kidney.Qi-benefiting and heart-nourishing, the improving inspiration by invigorating kidney-QI that reinforces the kidney, depressed lung-energy dispersing.Prescription rationally, science, method for preparing is simple, control of quality, and cure rate easily is high, be difficult for recurrence, have no side effect.
The specific embodiment
Below principle of the present invention and characteristic are described, institute gives an actual example and only is used to explain the present invention, is not to be used to limit scope of the present invention.
Pulmonary heart disease (abbreviation pulmonary heart disease); Be a kind of commonly encountered diseases, the frequently-occurring disease of serious harm people ' s health; Because lung, thorax or Pulmonic chronic pathological changes cause pulmonary hypertension, right chronic cardiac load overweight; Caused ventricle to enlarge or plumpness, a kind of Secondary cases heart disease of heart failure has taken place at last.In motherland's medical science, though there is not identical or corresponding name of disease, more to the record of its similar syndrome from allusion doctor nationality document, this respect record is promptly arranged in the Huangdi's Internal Classics, say like " Ling Shu Miraculous Pivot or Divine Axis expands and discusses ": " pulmonary distension person, asthenia-fullness and dyspnea with cough." the Han dynasty Zhang Zhongjing down in book, also further described the disease of " proptosis " at " Medical Treasures of the Golden Chamber ", carry in the Song dynasty " Shengji Zonglu ": " aqueous vapor cough with dyspnea the whole body serious edema, the distension of losing heart must not crouch round the clock." in bright clear doctor's nationality, to heart failure, the passive congestion of lungs, similar disease such as pulmonary edema have many penetrating argumentations.Warp is summed up " the QI invigorating Heart replenishing capsule " of our research and development for many years to preventing and treating primary disease and seeking combination of Chinese and Western medicine approach, and certain value is all arranged.It is main along with the blood circulation promoting and blood stasis dispelling progress of research that the paracmastic patient of pulmonary heart disease is adopted traditional Chinese medical science strengthening the body resistance and vital energy regualting and blood circulation-promoting; We find that progressively syndrome of blood stasis is the key link that forms the pulmonary heart disease etiology and pathogenesis;, rule of treatment research, square medicine effect aspect; Obtained good experience, for the treatment pulmonary heart disease has been opened up wide prospect and through the overall process of pulmonary heart disease.Therefore, blood circulation promoting and blood stasis dispelling becomes the important rule of treatment of pulmonary heart disease.Inquire at pathology." QI invigorating Heart replenishing capsule " prevented and treated the effectiveness of pulmonary heart disease, confirmed with experimentation by clinical.Radix Salviae Miltiorrhizae among its side, Pheretima, Semen Persicae, Lignum Sappan, Gecko, Radix Ginseng, the Radix Astragali has benefiting QI for activating blood circulation, and the merit of helping inspiration to relieve asthma is monarch drug altogether; Radix Aconiti Lateralis Preparata, Ramulus Cinnamomi, Semen Lepidii (Semen Descurainiae), the Rhizoma Atractylodis Macrocephalae, Rhizoma Dioscoreae, Herba Epimedii, Fructus Psoraleae have supporing yang diuretic, and the merit of invigorating spleen to remove dampness is ministerial drug altogether; Semen Armeniacae Amarum, the Radix Stemonae, Flos Farfarae, Radix Ophiopogonis, Herba Houttuyniae, Herba Epimedii, Fructus Psoraleae, have the merit that relieving cough and moistening lung reduces phlegm and be adjuvant drug altogether; Fructus Schisandrae Chinensis, Radix Glycyrrhizae Preparata have the convergence lung qi, and reinforce functional activities of the heart coordinating the actions of various ingredients in a prescription simultaneously is messenger drug altogether.More than all medicines play benefiting QI for activating blood circulation jointly, helping inspiration to relieve asthma, lung qi dispersing cough-relieving.
Clinical report:
Data and method
1. physical data:
200 examples are Xianghe County tracheitis, asthma section of tracheitis, asthma hospital inpatient, adopt the randomized, double-blind principle to be divided into 2 groups.100 examples are organized in treatment, male 54 examples, women 46 examples; 45～78 years old age, average (61.3 ± 8.4) year; The course of disease 15～40 years, average (26 ± 4.6) year.Matched group 100 examples, male 52 examples, women 48 examples; 42～76 years old age, average (58 ± 9.2) year; The course of disease 14～30 years, average (22 ± 4.3) year.2 groups of physical data comparing difference not statistically significants (P＞0.05) have comparability.
2. diagnostic criteria:
Western medicine diagnose reference year 13 editions " practical internal medicine " tcm diagnosis and differentiation of symptoms and signs for classification of syndrome are with reference to State Administration of Traditional Chinese Medicine " traditional Chinese medical science disease diagnosis criterion of therapeutical effect ".
2.1 the standard of including in:
Meet the diagnosis diagnosis; 42～78 years old year of age; The course of disease was in 14～40 years; Inpatient; I know the inside story
2.2 observation index:
With reference to the symptom scalar quantization standard of listing in " new Chinese medicine clinical research guideline " [4] in 2002; In conjunction with every of being seen symptom in clinical (cough, expectoration, tachypnea, movable back cardiopalmus) by light, in, 2 minutes heavily respectively, 4 minutes, 6 minutes; Every of inferior disease (appetite, bitter taste, constipation, breathe hard) was by in light 1 minute heavily respectively, 3 minutes, 5 minutes; Before and after the treatment item by item inquiry observe, calculate also record total mark, observed and recorded picture of the tongue, pulse condition but do not score.
2.3 criterion of therapeutical effect:
With reference to the therapeutic effect of syndrome criterion in " new Chinese medicine clinical research guideline ".Produce effects: original symptom complete obiteration or significantly alleviate, symptom integral reduces >=70%; Effectively: original symptom takes a turn for the better to some extent or alleviates, symptom integral reduce >=30% but＜70%; Invalid: original symptom does not have improvement, and symptom integral reduces＜30%.
3. result:
Two groups of Comparison of therapeutic
The result shows: the result shows: produce effects 76 examples, effective 15 examples, invalid 9 examples, total effective rate 91.0%.
4. model case
Embodiment 1:
Above-mentioned raw materials is prepared into hard capsule by " the preparation quality standard JZBZ20090678 of medical institutions of Hebei province's food and medicine Surveillance Authority " prescriptive procedure, uses after the assay was approved.
Hao so-and-so, the man, 58 years old, people from Handan County, Hebei province, suffer from breathe heavily after chronic obstructive pulmonary disease, chronic pulmonary property heart disease companion cough, the expectoration activity suppress 10 surplus year, increased the weight of 4 years.In western medical treatments such as local dead point infection suppressing panting calming medicines, poor effect comes me institute to be in hospital; Take 6 of the hard capsules that embodiment 1 processes at every turn, every day 3 times, took continuously 150 days; The two pulmonary respiration sounds in treatment back are thick, and dried moist rales disappears, and two lower limbs edema disappear; Transference cure, vital capacity increases to 2100ml by 500ml, not recurrence.
Lou so-and-so, the woman, 66 years old, people from Duolun County, the Inner Mongol, suffer from that chronic obstructive pulmonary disease, bronchiectasis, chronic pulmonary heart disease companion are coughed, expectorant, breathe heavily suppress 10 surplus year, increased the weight of 2 years.In doctor trained in Western medicine conventional therapies such as local hospital dead point medicines, effect is not good enough, comes my institute to be in hospital, and takes 6 of the hard capsules that embodiment 1 processes at every turn; Every day 3 times, to take continuously 180 days, the two pulmonary respiration sounds in treatment back are low, and dried moist rales disappears; Two lower limbs edema disappear, transference cure, not recurrence.
Embodiment 2:
Above-mentioned raw materials is prepared into hard capsule by " the preparation quality standard JZBZ20090678 of medical institutions of Hebei province's food and medicine Surveillance Authority " prescriptive procedure, uses after the assay was approved.
Shen so-and-so, man, 62 years old, Hinggan League Horqin right flank people in early stage.In year surplus trouble chronic obstructive pulmonary disease, chronic pulmonary heart disease companion cough, expectoration, the asthma 15, increase the weight of 3 years once in the conventional western medical treatment of local hospital, poor effect.Come my institute to go to a doctor, take 6 of the hard capsules that embodiment 2 processes at every turn, took continuously 150 days every day 3 times, two pulmonary respiration sounds are low behind the hospitalization, and the trusted subordinate is negative, and two lower limbs edema disappear, and vital capacity increases to 1000ml by 100ml, transference cure, recurrence.
Embodiment 3:
Radix Ginseng 60g 60g Radix Ophiopogonis Fructus Schisandrae Chinensis 60g,
Rhizoma Atractylodis Macrocephalae 60g Lignum Sappan 60g Ramulus Cinnamomi 30g,
Radix Astragali 60g Radix Salviae Miltiorrhizae 60g Radix Aconiti Lateralis Preparata 60g,
Gecko 50g Herba Epimedii 60g Rhizoma Dioscoreae 60g,
Semen Armeniacae Amarum 60g Fructus Psoraleae 60g Semen Lepidii (Semen Descurainiae) 60g,
Radix Stemonae 60g Poria 60g Semen Persicae 60g,
Flos Farfarae 60g Radix Glycyrrhizae Preparata 30g Pheretima 60g
Herba Houttuyniae 60g
Above-mentioned raw materials is prepared into hard capsule by " the preparation quality standard JZBZ20090678 of medical institutions of Hebei province's food and medicine Surveillance Authority " prescriptive procedure, uses after the assay was approved.
The king so-and-so, man, 63 years old, Shanxi Province Wuxiang County people; Suffer from surplus chronic obstructive pulmonary disease, obstructive emphysema, the chronic pulmonary heart disease 30 year, increased the weight of 4 years, be in hospital, take 6 of the hard capsules that embodiment 3 processes at every turn; Every day 3 times, took continuously 180 days, fully recover after treating 3 courses of treatment.
Embodiment 4:
Above-mentioned raw materials is prepared into hard capsule by " the preparation quality standard JZBZ20090678 of medical institutions of Hebei province's food and medicine Surveillance Authority " prescriptive procedure, uses after the assay was approved.
Yan so-and-so, man, 55 years old, Ulan, Inner Mongol Cha Bushi people; Suffered from chronic obstructive pulmonary disease, chronic pulmonary heart disease 15 years, increased the weight of 1 year, through treatments such as local certain hospital's doctor trained in Western medicine antiinflammatories; Effect is not good enough, comes my institute to be in hospital, and takes 6 of the hard capsules that embodiment 4 processes at every turn; Every day 3 times, took the recovery from illness of treatment back continuously 160 days.
The above is merely preferred embodiment of the present invention, and is in order to restriction the present invention, not all within spirit of the present invention and principle, any modification of being done, is equal to replacement, improvement etc., all should be included within protection scope of the present invention.
Claims (3)
1. Chinese medicine that is used to treat chronic pulmonary heart disease; It is characterized in that its raw material and parts by weight thereof comprise: 10～15 parts of 10～15 parts of Radix Ginsengs, 10～15 parts of Radix Ophiopogonis, 10～15 parts of Fructus Schisandrae Chinensis, 10～15 parts of the Rhizoma Atractylodis Macrocephalaes, 10～15 parts of Lignum Sappans, 5～8 parts of Ramulus Cinnamomi, 10～15 parts of the Radixs Astragali, 10～15 parts of Radix Salviae Miltiorrhizaes, 10～15 parts of Radix Aconiti Lateralis Preparata, 8～12 parts of Geckos, 10～15 parts of Herba Epimedii, 10～15 parts of Rhizoma Dioscoreaes, 10～15 parts of Semen Armeniacae Amarums, 10～15 parts of Fructus Psoraleaes, 10～15 parts of Semen Lepidii (Semen Descurainiae)s, 10～15 parts of the Radixs Stemonae, 10～15 parts in Poria, 10～15 parts in Semen Persicae, 10～15 parts of Flos Farfaraees, 5～8 parts of Radix Glycyrrhizae Preparatas, 10～15 parts of Pheretimas and Herba Houttuyniae.
2. the Chinese medicine that is used to treat chronic pulmonary heart disease according to claim 1; It is characterized in that its raw material and parts by weight thereof comprise: 11～14 parts of 11～14 parts of Radix Ginsengs, 11～14 parts of Radix Ophiopogonis, 11～14 parts of Fructus Schisandrae Chinensis, 11～14 parts of the Rhizoma Atractylodis Macrocephalaes, 11～14 parts of Lignum Sappans, 5～7 parts of Ramulus Cinnamomi, 11～14 parts of the Radixs Astragali, 11～14 parts of Radix Salviae Miltiorrhizaes, 11～14 parts of Radix Aconiti Lateralis Preparata, 9～11 parts of Geckos, 11～14 parts of Herba Epimedii, 11～14 parts of Rhizoma Dioscoreaes, 11～14 parts of Semen Armeniacae Amarums, 11～14 parts of Fructus Psoraleaes, 11～14 parts of Semen Lepidii (Semen Descurainiae)s, 11～14 parts of the Radixs Stemonae, 11～14 parts in Poria, 11～14 parts in Semen Persicae, 11～14 parts of Flos Farfaraees, 5～7 parts of Radix Glycyrrhizae Preparatas, 11～14 parts of Pheretimas and Herba Houttuyniae.
3. the Chinese medicine that is used to treat chronic pulmonary heart disease according to claim 1; It is characterized in that its raw material and parts by weight thereof comprise: 12 parts of 12 parts of Radix Ginsengs, 12 parts of Radix Ophiopogonis, 12 parts of Fructus Schisandrae Chinensis, 12 parts of the Rhizoma Atractylodis Macrocephalaes, 12 parts of Lignum Sappans, 6 parts of Ramulus Cinnamomi, 12 parts of the Radixs Astragali, 12 parts of Radix Salviae Miltiorrhizaes, 12 parts of Radix Aconiti Lateralis Preparata, 10 parts of Geckos, 12 parts of Herba Epimedii, 12 parts of Rhizoma Dioscoreaes, 12 parts of Semen Armeniacae Amarums, 12 parts of Fructus Psoraleaes, 12 parts of Semen Lepidii (Semen Descurainiae)s, 12 parts of the Radixs Stemonae, 12 parts in Poria, 12 parts in Semen Persicae, 12 parts of Flos Farfaraees, 6 parts of Radix Glycyrrhizae Preparatas, 12 parts of Pheretimas and Herba Houttuyniae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011103976125A CN102441129B (en) | 2011-12-02 | 2011-12-02 | Traditional Chinese medicine for treating chronic pulmonary heart disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011103976125A CN102441129B (en) | 2011-12-02 | 2011-12-02 | Traditional Chinese medicine for treating chronic pulmonary heart disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102441129A true CN102441129A (en) | 2012-05-09 |
| CN102441129B CN102441129B (en) | 2013-07-17 |
Family
ID=46004389
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011103976125A Active CN102441129B (en) | 2011-12-02 | 2011-12-02 | Traditional Chinese medicine for treating chronic pulmonary heart disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102441129B (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103520693A (en) * | 2013-10-23 | 2014-01-22 | 孙丽 | Traditional Chinese medicine for treating heart-lung qi-deficiency syndrome type angina pectoris |
| CN104547539A (en) * | 2013-10-28 | 2015-04-29 | 杨少梅 | Medicament for preventing and treating asthma recurrence and preparation method thereof |
| CN105853989A (en) * | 2016-06-20 | 2016-08-17 | 孙玉红 | Traditional Chinese medicine preparation for treating chronic pulmonary heart disease |
| CN108498742A (en) * | 2018-05-30 | 2018-09-07 | 韩庆捷 | Purging the lung of pathogenic fire is by the relieving cough and asthma Chinese medicine of drink |
| CN108553607A (en) * | 2018-05-30 | 2018-09-21 | 韩庆捷 | Tonifying lung kidney is relieving cough and asthma Chinese medicine |
| CN108685994A (en) * | 2018-06-13 | 2018-10-23 | 浙江中医药大学 | It is a kind of to treat cold solidifying, blood-vessel obstructive card the Chinese medicine composition of the coronary heart disease deficiency of yang |
| CN109568589A (en) * | 2019-01-24 | 2019-04-05 | 陕西中医药大学 | A kind of pharmaceutical composition for treating heart failure |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1310000A (en) * | 2001-02-19 | 2001-08-29 | 孟庆云 | Combined Chinese and Western medicine for treating cardiopulmonary disease in catabasis |
| CN101843874A (en) * | 2010-06-01 | 2010-09-29 | 张桂忠 | Chinese medicament for treating emphysema |
| CN102038809A (en) * | 2009-10-15 | 2011-05-04 | 张红旗 | Traditional Chinese medicine formula for treating chronic pulmonary heart disease |
| CN102058784A (en) * | 2009-11-12 | 2011-05-18 | 王占波 | Medicinal composition for treating pulmonary heart disease and application thereof |
-
2011
- 2011-12-02 CN CN2011103976125A patent/CN102441129B/en active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1310000A (en) * | 2001-02-19 | 2001-08-29 | 孟庆云 | Combined Chinese and Western medicine for treating cardiopulmonary disease in catabasis |
| CN102038809A (en) * | 2009-10-15 | 2011-05-04 | 张红旗 | Traditional Chinese medicine formula for treating chronic pulmonary heart disease |
| CN102058784A (en) * | 2009-11-12 | 2011-05-18 | 王占波 | Medicinal composition for treating pulmonary heart disease and application thereof |
| CN101843874A (en) * | 2010-06-01 | 2010-09-29 | 张桂忠 | Chinese medicament for treating emphysema |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103520693A (en) * | 2013-10-23 | 2014-01-22 | 孙丽 | Traditional Chinese medicine for treating heart-lung qi-deficiency syndrome type angina pectoris |
| CN103520693B (en) * | 2013-10-23 | 2015-05-27 | 李贞福 | Traditional Chinese medicine for treating heart-lung qi-deficiency syndrome type angina pectoris |
| CN104547539A (en) * | 2013-10-28 | 2015-04-29 | 杨少梅 | Medicament for preventing and treating asthma recurrence and preparation method thereof |
| CN105853989A (en) * | 2016-06-20 | 2016-08-17 | 孙玉红 | Traditional Chinese medicine preparation for treating chronic pulmonary heart disease |
| CN108498742A (en) * | 2018-05-30 | 2018-09-07 | 韩庆捷 | Purging the lung of pathogenic fire is by the relieving cough and asthma Chinese medicine of drink |
| CN108553607A (en) * | 2018-05-30 | 2018-09-21 | 韩庆捷 | Tonifying lung kidney is relieving cough and asthma Chinese medicine |
| CN108685994A (en) * | 2018-06-13 | 2018-10-23 | 浙江中医药大学 | It is a kind of to treat cold solidifying, blood-vessel obstructive card the Chinese medicine composition of the coronary heart disease deficiency of yang |
| CN109568589A (en) * | 2019-01-24 | 2019-04-05 | 陕西中医药大学 | A kind of pharmaceutical composition for treating heart failure |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102441129B (en) | 2013-07-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102441129B (en) | Traditional Chinese medicine for treating chronic pulmonary heart disease | |
| CN102058784A (en) | Medicinal composition for treating pulmonary heart disease and application thereof | |
| CN102441105A (en) | Chinese herbal medicine for treating trachitis and asthma | |
| CN102416129A (en) | Chinese medicine for treating paracmastic chronic obstructive pulmonary disease | |
| CN102512552B (en) | Traditional Chinese medicine composition for treating exogenous fever | |
| CN102416096B (en) | Traditional Chinese medicine for treating bronchiectasis | |
| CN102935214B (en) | Traditional Chinese medicinal composition for treating uremia | |
| CN101843874B (en) | Chinese medicament for treating emphysema | |
| CN105596930A (en) | Fermentation microorganism Chinese herb preparation for tracheopathy and preparation method and application of fermentation microorganism Chinese herb | |
| CN104027760A (en) | Traditional Chinese medicament for treating wind-phlegm in lung type asthma | |
| CN102743708B (en) | Cordyceps sinensis and gecko powder for treating emphysema pulmonary heart disease asthma chronic bronchitis | |
| CN103127411A (en) | Traditional Chinese medicine used for treating urinary tract infection disease | |
| CN108310243A (en) | Chinese medicine and preparation method thereof for specially controlling heredity icterohepatitis | |
| CN103705787B (en) | One is treated myocarditic Chinese medicine preparation | |
| CN106729097A (en) | A kind of Chinese medicine composition for treating wind-warm lung-heat | |
| CN105770520A (en) | Medicine preparation used for treating coronary heart disease and application thereof | |
| CN105288143A (en) | Traditional Chinese medicine composition for treating asthma | |
| CN103705893B (en) | One treats the emophysematous Chinese medicine composition of external cold internal rheum type | |
| CN103599341B (en) | A kind of pharmaceutical composition for the treatment of cough with asthma | |
| CN103127284A (en) | Xianqi formula capable of strengthening yang-qi and healthy energy and preparation method | |
| CN102641374B (en) | Traditional Chinese decoction for treating chronic bronchitis | |
| CN108686087A (en) | A kind of dyspeptic Chinese medicine of medicine for treatment of diet stagnation type | |
| CN102614480A (en) | Traditional Chinese medicine lotion preparation method for curing stomach-yin deficiency ecthyma | |
| CN108578674A (en) | A kind of depressing Qi and relieving asthma removes the Chinese medicine preparation of phlegm and relieving cough | |
| CN109674935A (en) | A kind of Chinese medicinal capsule for treating hyperglycemia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |